These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9689314)

  • 1. Oral terbinafine in the treatment of griseofulvin-resistant Tinea capitis et faciei et corporis in a 10-month-old girl.
    Wilmer A; Wollina U
    Acta Derm Venereol; 1998 Jul; 78(4):314. PubMed ID: 9689314
    [No Abstract]   [Full Text] [Related]  

  • 2. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.
    Elewski BE; Cáceres HW; DeLeon L; El Shimy S; Hunter JA; Korotkiy N; Rachesky IJ; Sanchez-Bal V; Todd G; Wraith L; Cai B; Tavakkol A; Bakshi R; Nyirady J; Friedlander SF
    J Am Acad Dermatol; 2008 Jul; 59(1):41-54. PubMed ID: 18378354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a 1-week, once-daily regimen of terbinafine 1% cream in the treatment of tinea cruris and tinea corporis.
    Zaias N; Berman B; Cordero CN; Hernandez A; Jacobson C; Millikan L; Rojas R; de la Rosa I; Villars V; Birnbaum JE
    J Am Acad Dermatol; 1993 Oct; 29(4):646-8. PubMed ID: 8408803
    [No Abstract]   [Full Text] [Related]  

  • 4. Meta-analysis of randomized, controlled trials comparing particular doses of griseofulvin and terbinafine for the treatment of tinea capitis.
    Gupta AK; Drummond-Main C
    Pediatr Dermatol; 2013; 30(1):1-6. PubMed ID: 22994156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcomes for tinea capitis in a skin of color population.
    Bhanusali D; Coley M; Silverberg JI; Alexis A; Silverberg NB
    J Drugs Dermatol; 2012 Jul; 11(7):852-6. PubMed ID: 22777228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative double-blind study of terbinafine (Lamisil) and griseofulvin in tinea corporis and tinea cruris.
    del Palacio Hernandez A; López Gómez S; González Lastra F; Moreno Palancar P; Iglesias Díez L
    Clin Exp Dermatol; 1990 May; 15(3):210-6. PubMed ID: 2194715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Griseofulvin and terbinafine in the treatment of tinea capitis in children.
    Rademaker M; Havill S
    N Z Med J; 1998 Feb; 111(1060):55-7. PubMed ID: 9539918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New treatments for tinea capitis.
    Chan YC; Friedlander SF
    Curr Opin Infect Dis; 2004 Apr; 17(2):97-103. PubMed ID: 15021047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis.
    Cole GW; Stricklin G
    Arch Dermatol; 1989 Nov; 125(11):1537-9. PubMed ID: 2684023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis.
    Tey HL; Tan AS; Chan YC
    J Am Acad Dermatol; 2011 Apr; 64(4):663-70. PubMed ID: 21334096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis.
    Cáceres-Ríos H; Rueda M; Ballona R; Bustamante B
    J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):80-4. PubMed ID: 10607324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
    Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
    Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral terbinafine in tinea capitis in children.
    Gruseck E; Splanemann V; Bleck O; Ring J; Abeck D
    Mycoses; 1996; 39(5-6):237-40. PubMed ID: 8909037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China.
    Deng S; Hu H; Abliz P; Wan Z; Wang A; Cheng W; Li R
    Mycopathologia; 2011 Nov; 172(5):365-72. PubMed ID: 21701791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.
    Fuller LC; Smith CH; Cerio R; Marsden RA; Midgley G; Beard AL; Higgins EM; Hay RJ
    Br J Dermatol; 2001 Feb; 144(2):321-7. PubMed ID: 11251566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic antifungal treatment of children with terbinafine.
    Bruckbauer HR; Hofmann H
    Dermatology; 1997; 195(2):134-6. PubMed ID: 9310719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of terbinafine in children.
    Gupta AK; Cooper EA; Lynde CW
    Dermatol Clin; 2003 Jul; 21(3):511-20. PubMed ID: 12956204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trichophyton tonsurans tinea capitis and tinea corporis: treatment and follow-up of four affected family members.
    Ravenscroft J; Goodfield MJ; Evans EG
    Pediatr Dermatol; 2000; 17(5):407-9. PubMed ID: 11085674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of oral terbinafine (Lamisil) in children.
    Krafchik B; Pelletier J
    Dermatology; 1997; 194 Suppl 1():43-4. PubMed ID: 9154402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
    Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.